Vitaz
Vitaz
Sint-Niklaas, Belgium11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 2 | 2026-09-28 | NCT05242484 | |
| A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 2 | 2026-09-28 | NCT05242471 | |
| Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06408935 | |
| Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes | Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, metabolic disease, pregnancy disorder, type 2 diabetes mellitus | Recruiting | Phase 3 | 2026-09-15 | NCT05569772 | |
| Open and Closed Loop DTM SCS in Patients With PSPS Type 2: ENDLESS Study | Back Pain, Failed Back Surgery Syndrome, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms | Recruiting | Not stated | 2026-08-17 | NCT07211308 | |
| Continuous Glucose Monitoring for Women With Gestational Diabetes | Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, metabolic disease, pregnancy disorder | Recruiting | Not applicable | 2026-06-09 | NCT06310356 | |
| GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP) | Bone Diseases, Developmental, Bone Diseases, Metabolic, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Femoral Fractures, Hip Injuries, Leg Injuries, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, bone fracture, connective tissue disorder, hereditary disease, hip fracture, hypophosphatasia, inborn errors of metabolism, inborn metal metabolism disorder, injury, metabolic disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta, osteoporosis | Not yet recruiting | Not stated | 2026-05-19 | NCT07594639 | |
| Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-02-10 | NCT05501886 | |
| ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC); Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Recruiting | Phase 3 | 2025-04-09 | NCT03903835 | |
| Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases | Neoplasms by Site, Spinal Neoplasms, bone disorder, central nervous system cancer, central nervous system disorder, musculoskeletal system disorder, neoplasm, nervous system disorder, spinal cord disorder, spinal cord neoplasm, vertebral column disorder | Recruiting | Not applicable | 2024-09-25 | NCT06613295 | |
| Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 4 | 2024-07-26 | NCT06113913 |